NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $229,697 | -10.5% | 6,354 | -1.9% | 0.00% | – |
| Q4 2022 | $256,529 | +16.6% | 6,478 | +37.5% | 0.00% | – |
| Q3 2022 | $220,000 | -19.7% | 4,712 | -24.7% | 0.00% | – |
| Q2 2022 | $274,000 | -15.7% | 6,261 | +39.3% | 0.00% | – |
| Q1 2022 | $325,000 | -5.2% | 4,495 | +6.4% | 0.00% | – |
| Q4 2021 | $343,000 | -40.0% | 4,226 | -14.0% | 0.00% | -100.0% |
| Q3 2021 | $572,000 | -60.9% | 4,913 | -44.3% | 0.00% | 0.0% |
| Q2 2021 | $1,463,000 | +48.5% | 8,822 | +25.0% | 0.00% | 0.0% |
| Q1 2021 | $985,000 | +14.5% | 7,060 | +42.1% | 0.00% | 0.0% |
| Q4 2020 | $860,000 | +72.3% | 4,969 | +38.7% | 0.00% | 0.0% |
| Q3 2020 | $499,000 | +42.2% | 3,582 | +21.9% | 0.00% | 0.0% |
| Q2 2020 | $351,000 | +65.6% | 2,939 | +38.9% | 0.00% | – |
| Q1 2020 | $212,000 | -14.9% | 2,116 | -0.2% | 0.00% | – |
| Q4 2019 | $249,000 | – | 2,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |